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Abstract. 
 
Angiotensin II (Ang II) exerts chronic stimu-
latory actions on tyrosine hydroxylase (TH), dopamine 
 
b
 
-hydroxylase (D
 
b
 
H), and the norepinephrine trans-
porter (NET), in part, by influencing the transcription 
of their genes. These neuromodulatory actions of Ang 
II involve Ras-Raf-MAP kinase signal transduction 
pathways (Lu, D., H. Yang, and M.K. Raizada. 1997. 
 
J. 
Cell Biol.
 
 135:1609–1617). In this study, we present evi-
dence to demonstrate participation of another signal-
ing pathway in these neuronal actions of Ang II. It 
involves activation of protein kinase C (PKC)
 
b
 
 subtype 
and phosphorylation and redistribution of myristoy-
lated alanine-rich C kinase substrate (MARCKS) in 
neurites. Ang II caused a dramatic redistribution of 
MARCKS from neuronal varicosities to neurites. This 
was accompanied by a time-dependent stimulation of 
its phosphorylation, that was mediated by the angio-
 
tensin type 1 receptor subtype (AT
 
1
 
). Incubation of 
neurons with PKC
 
b
 
 subtype specific antisense oligonu-
cleotide (AON) significantly attenuated both redistri-
bution and phosphorylation of MARCKS. Further-
more, depletion of MARCKS by MARCKS-AON 
treatment of neurons resulted in a significant decrease 
in Ang II–stimulated accumulation of TH and D
 
b
 
H im-
munoreactivities and [
 
3
 
H]NE uptake activity in synap-
tosomes. In contrast, mRNA levels of TH, D
 
b
 
H, and 
NET were not influenced by MARKS-AON treatment. 
MARCKS pep
 
148–165
 
, which contains PKC phosphoryla-
tion sites, inhibited Ang II stimulation of MARCKS 
phosphorylation and reduced the amount of TH, D
 
b
 
H, 
and [
 
3
 
H]NE uptake in neuronal synaptosomes. These 
observations demonstrate that phosphorylation of 
MARCKS by PKC
 
b
 
 and its redistribution from vari-
cosities to neurites is important in Ang II–induced syn-
aptic accumulation of TH, D
 
b
 
H, and NE. They suggest 
that a coordinated stimulation of transcription of TH, 
D
 
b
 
H, and NET, mediated by Ras-Raf-MAP kinase fol-
lowed by their transport mediated by PKC
 
b
 
-MARCKS 
pathway are key in persistent stimulation of Ang II’s 
neuromodulatory actions.
Key words: MARCKS • brain neurons • AT
 
1
 
 recep-
tors • neuromodulation • protein kinase C subtypes
 
E
 
vidence
 
 has been accumulating that angiotensin II
(Ang II)
 
1
 
 exerts diverse physiological actions in
both peripheral and neural tissues. In the periph-
ery, its actions include vasoconstriction, hypertrophy, cell
multiplication, and tissue remodeling, whereas the central
nervous system (CNS) actions of Ang II include neuroen-
docrine hormone secretion, regulation of sympathetic acti-
vation and dampening of baroreceptor function (Saave-
dra, 1992; Steckeling et al., 1992; Dzau, 1993; Timmermans
et al., 1993; Naftilan, 1994; Raizada et al., 1994; Wright and
Harding, 1994). Sympathetic activation of the CNS neu-
rons by Ang II is associated with the stimulation of turn-
over, synthesis, and release of catecholamines (Steckeling
et al., 1992; Gelband et al., 1998). All of these diverse
physiological effects of Ang II are mediated by its interac-
tion with the angiotensin type 1 receptor subtype (AT
 
1
 
 re-
ceptor), and that such diversity may stem from coupling of
the receptor to various signal transduction pathways. For
example, the vascular smooth muscle cell AT
 
1
 
 receptor is
linked to the JAK-STAT signaling system that mediates
Ang II’s effects on DNA replication, hypertrophy, and ex-
tracellular matrix; whereas neuronal AT
 
1
 
 receptor is cou-
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pled to the Ras-Raf-MAP kinase signaling pathway, which
regulates enhanced neuromodulatory actions of Ang II in-
cluding stimulation of tyrosine hydroxylase (TH), dopamine
 
b
 
-hydroxylase (D
 
b
 
H), and norepinephrine transporter
(NET) (Marrero et al., 1995; Lu et al., 1996, 1997; Yang et
al., 1996; Yu et al., 1996; Gelband et al., 1998).
In addition to its coupling with JAK-STAT and Ras-
Raf-MAP kinase pathways, the AT
 
1
 
 receptor is also cou-
pled to the phospholipase C–phosphoinositide–protein ki-
nase C (PKC) signaling system (Sumners and Raizada,
1993; Freeman et al., 1995). Studies have established that
AT
 
1
 
 receptor stimulation increases inositol phosphate (IP)
formation, stimulates PKC, and mobilizes Ca
 
2
 
1
 
 from IP
 
3
 
-
sensitive pools in both brain neurons and peripheral cells
(Sumners and Raizada, 1993; Freeman et al., 1995). This
pathway is particularly important in neurons because both
Ca
 
2
 
1
 
 mobilization and PKC activation are involved in the
synthesis, release, and re-uptake of many neurotransmit-
ters (Zhu and Ikeda, 1994; Patel et al., 1995). Since Ang II
regulates neurotransmitter synthesis and release, it was of
great importance for us to further delineate the mecha-
nism of PKC involvement in Ang II–induced neuromodu-
lation. In this study we focused our attention on myristoy-
lated alanine-rich C-kinase substrate (MARCKS) since it
is a major PKC substrate, exists in high concentrations in
neurons, and has been implicated in cytoskeletal rear-
rangement, membrane trafficking, and neurotransmitter
release (Wang et al., 1989; Aderem, 1995; Blackshear, 1993;
Manenti et al., 1994). In spite of well-defined roles of
MARCKS in cell motility and membrane trafficking, little
is known about its involvement in neurotransmitter syn-
thesis and release, including its role in enhanced neuro-
Figure 1. Effects of Ang II on TH, DbH immu-
noreactivities, and [3H]NE uptake in synapto-
somes and whole cells of brain neurons. (A–C)
Neuronal cultures were incubated with 100 nM
Ang II for indicated time periods, synapto-
somes were prepared and subjected to quantita-
tion of TH (A) and DbH (B) immunoreactivi-
ties, and [3H]NE uptake (C) activities essentially
as described in Materials and Methods. A com-
parable amount of proteins in each sample were
also electrophoresed and subjected to Western
blotting with the use of antibodies to synapto-
physin. Top in A and B are representative auto-
radiograms. Bottom in A and B are mean data
from three experiments mean 6 SE. Data in C
are mean 6 SE (n 5 3). *, significantly different
(P , 0.01) from zero time. (D and E) TH and
DbH levels in whole cells and synaptosomes.
After treatment with Ang II for 4 h essentially
as described above, whole neuronal cells and
synaptosomal preparation from them were sub-
jected to TH (D) and DbH (E) Western blot-
ting. Equal amounts of proteins (20 mg) were
used for electrophoresis. Top in D and E are
representative autodiagrams. Bottom, mean data
from two experiments. 
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modulation. In addition, the role of MARCKS in any G
protein–coupled receptor’s signal transduction propaga-
tion is even less understood. In view of these gaps in our
understanding, coupled with our observation that AT
 
1
 
 re-
ceptors stimulate PKC and neuromodulation, the objec-
tive in this investigation was to test the following hypothe-
sis: Ang II interaction with the neuronal AT
 
1
 
 receptor
stimulates phosphorylation of MARCKS by PKC. Phos-
phorylated MARCKS redistributes itself in a way to facili-
tate the transport of TH, D
 
b
 
H, and NET along the neu-
rites to synaptic vesicles where they participate in increased
synthesis, release, and re-uptake of norepinephrine (NE).
Observations presented in this study provide evidence in
support of this hypothesis.
 
Materials and Methods
 
1-d-old Wistar Kyoto (WKY) rats were obtained from our breeding col-
ony, which originated from Harlan Sprague-Dawley (Indianapolis, IN).
DME, plasma-derived horse serum (PDHS), and 1
 
3
 
 crystal trypsin were
from Central Biomedia (Irwin, MO). Phosphate-free DME was purchased
from Life Technologies (Grand Island, NY). [
 
32
 
P]Orthophosphate (1 mCi 
 
5
 
37 MBq), [
 
g
 
-
 
32
 
P]ATP (3,000 Ci/mmol), dl[
 
3
 
H]NE (10.4 Ci/mmol), and
chemiluminescence assay reagents were from Dupont/NEN (Boston,
MA). Nitrocellulose membrane was from Micron Separations, Inc. (West-
boro, MA). Ang II and mAb to synaptophysin were purchased from
Sigma Chemical Co. (St. Louis, MO). Polyclonal antibodies to TH and
D
 
b
 
H were obtained from Chemicon (Temecula, CA). Rabbit polyclonal
antibodies to various isoforms of PKC (
 
a
 
, 
 
b
 
, 
 
g
 
) and agarose-conjugated
protein A/G were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Specificity of these antibodies to respective PKC subtypes is well estab-
lished by both immunocytochemical staining and by immunoblotting
(Asotra and Macklin, 1994; Kim et al., 1994; Sylvia et al., 1996). Anti–rab-
bit and anti–mouse Fab fragments conjugated with rhodamine or fluores-
cein were from Boehringer Mannheim, Co. (Indianapolis, IN). All other
reagents were purchased from Fisher Scientific (Pittsburgh, PA), and
were the highest quality available.
Sense and antisense oligonucleotides to MARCKS and PKC
 
a
 
, PKC
 
b
 
,
and PKC
 
g
 
 were synthesized in the DNA synthesis facility of the Interdis-
ciplinary Center for Biotechnology Research, University of Florida
(Gainesville, FL). These sequences have been used successfully to down-
regulate MARCKS and PKC by other groups (Aigner and Caroni, 1993;
Balboa et al., 1994). The sequences are listed as follows:
MARCKS: Sense: 5
 
9
 
-AAGAAGCCAGCATGGGTGCACAGTT-3
 
9
 
Antisense: 5
 
9
 
-AACTGTGCACCCATGCTGGCTTCTT-3
 
9
 
PKC
 
a
 
: Sense: 5
 
9
 
-GAACCATGGCTGACGTTTACC-3
 
9
 
Antisense: 5
 
9
 
-GGTAAACGTCAGCCATGGTTC-3
 
9
 
PKC
 
b
 
: Sense: 5
 
9
 
-AAGATGGCTGACCCGGCTCGC-3
 
9
 
Antisense: 5
 
9
 
-CGCAGCCGGGTGACCCGGCCGC-3
 
9
 
PKC
 
g
 
: Sense: 5
 
9
 
-CAAGATGGCTGACCCGGCCGC-3
 
9
 
Antisense: 5
 
9
 
-GCGGCCGGGTCAGCCATCTTG-3
 
9
 
A synthetic peptide corresponding to amino acids 148–165 of
MARCKS (KRFSFKKSFKLSGFSFKK; pep
 
148–165
 
) and its mutant coun-
terpart in which serines at positions 151, 155, 159, and 162, were replaced
by alanine (KRFAFKKAFKLAGFAFKK; mut
 
148–165
 
) were synthesized
by Genemed Biotechnologies (San Francisco, CA). Pep
 
148–165
 
 competes
for PKC-mediated phosphorylation of MARCKS since three out of the
four serines (151, 155, and 162) in this molecule are known PKC phos-
phorylation sites (Amess et al., 1992). In contrast, mut
 
148–165
 
 would not be
a competitor, and thus serves as control for pep
 
148–165
 
.
 
Preparation of Neuronal Cultures
 
Hypothalamus–brainstem areas of 1-d-old WKY rat brains were dissected
and brain cells were dissociated by trypsin as described previously
(Raizada et al., 1984, 1993). Dissociated brain cells were plated in poly-
 
l
 
-lysine–precoated tissue culture dishes (2
 
 3 
 
10
 
7
 
 cells/100-mm-diam dish
or 3 
 
3 
 
10
 
6
 
 cells/35-mm-diam dish) in DME containing 10% PDHS and
neuronal culture established as previously described (Raizada et al., 1984,
1993). The cultures were allowed to grow for 15 d before their use in ex-
periments. These cultures contain 85–90% neuronal cells and 10–15% as-
troglial cells (Raizada et al., 1984, 1993).
 
Determination of TH, D
 
b
 
H Immunoreactivities, and 
Specific [
 
3
 
H]NE Uptake in Synaptosomal Preparations 
of Neuronal Cells
 
Neuronal cells, established in 100-mm-diam tissue culture dishes, were
subjected to various pretreatments followed by incubation with 100 nM
Ang II for indicated time periods. Cells from 10 culture dishes were col-
lected, cell pellets homogenized in 0.32 M sucrose, and then homogenates
were used for synaptosomal preparation essentially as described else-
where for neuronal cultures (Kishi et al., 1991). Purity of the synaptoso-
mal fraction was established with the use of synaptophysin antibody as
marker (Kishi et al., 1991). Synaptosomal preparations containing 100 
 
m
 
g
protein were subjected to 4–15% SDS-PAGE, separated proteins were
transferred to nitrocellulose membrane, and then blotted with the use of
1 
 
m
 
g/ml anti-TH or anti-D
 
b
 
H antibodies essentially as described previ-
ously (Lu et al., 1997). Antibodies bound to TH or D
 
b
 
H were identified
by HRP-labeled anti–rabbit antibody and visualized by chemiluminescence
as described previously (Yang et al., 1996; Lu et al., 1997). Bands corre-
sponding to TH and D
 
b
 
H immunoreactivities were quantitated by SW5000
Gel Analyzer after ascertaining that densities of each immunoreactive band
was within the linear range as described previously (Lu et al., 1996, 1997;
Yang et al., 1996).
Specific [
 
3
 
H]NE uptake was measured by incubating synaptosomal
preparations containing 1 mg protein with 1 nM [
 
3
 
H]NE (2 
 
m
 
Ci) in the ab-
sence or presence of 1 
 
m
 
M maprotiline essentially as described previously
Figure 2. (A) Effect of PKCb
AON on PKCa, PKCb, and
PKCg immunoreactivities in
brain neurons. Neuronal cul-
tures were incubated with 2.5
mM PKCb AON or SON for
indicated time periods. Cells
were lysed and lysates were
used for Western blot to deter-
mine levels of PKCb, PKCa,
and PKCg as described in the
Materials and Methods. Top,
a representative autoradio-
gram.  Bottom, data from three
experiments mean 6 SE. *, sig-
nificantly  different from con-
trol (P , 0.05). (B) Effects of
PKCa and PKCg AON and SON on PKCa and PKCg immunoreactivities in brain neurons. Neuronal cultures were treated with 2.5 mM
PKCa or PKCg AON or SON for 48 h at 378C essentially as described for PKCb above. Levels of PKCa and PKCg was determined by
Western blot. Top, representative autoradiogram. Bottom, mean 6 SE (n 5 3).The Journal of Cell Biology, Volume 142, 1998 220
(Lu et al., 1996). Specific uptake was calculated by subtracting the total
[3H]NE uptake from that in the presence of maprotiline.
Western Blotting of PKCa, b, and g Subtypes
and MARCKS
Western blotting was used to identify and quantitate the PKCa, PKCb,
PKCg, and MARCKS proteins essentially as described previously (Yang
et al., 1996). Briefly, cell-free lysates were prepared and electrophoresed
on 10% SDS-PAGE and then proteins were transferred to nitrocellulose
membranes. Membranes were treated with 5% nonfat dry milk in TBST
(20 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) for 1 h,
followed by incubation with rabbit anti–PKC subtype antibodies (1 mg/ml)
or rabbit anti-MARCKS antibody (1 mg/ml), and then incubated with
HRP-labeled anti–rabbit antibody, and enhanced chemiluminescence as-
say reagents. Densities in each band was quantitated by SW5000 Gel Ana-
lyzer (Lu et al., 1996, 1997).
Immunofluorescent Staining of Neurons for MARCKS
Neuronal cells, established in 35-mm-diam culture dishes, were fixed in
methanol at 2108C, and then incubated with rabbit anti-MARCKS anti-
body (1:200 diluted antiserum) in PBS containing 0.5% BSA overnight at
48C. Specificity of this antibody has been previously established (Watson
and Lenox, 1996). After removal of primary antibody, cells were incu-
bated with FITC-conjugated anti–rabbit IgG (1 mg/ml), and then pro-
cessed for confocal microscopy (Yang et al., 1996; Lu et al., 1997). For
colocalization of MARCKS with synaptophysin, cells were first stained
with anti-MARCKS antibody followed by incubation with mAb to synap-
tophysin (1 mg/ml in PBS) for 1 h at 378C. Cells were stained with
rhodamine-conjugated anti–mouse IgG (1 mg/ml) and subjected to confo-
cal microscopy (Yang et al., 1996; Lu et al., 1997).
Labeling of Neurons with [32P]Orthophosphate and 
Analysis of Phosphorylated MARCKS
Neuronal cells, established in 100-mm-diam culture dishes, were rinsed
once with phosphate-free DME, followed by incubation in the phosphate-
free DME containing 10% dialyzed PDHS for 4 h at 378C. [32P]Orthophos-
phate (1 mCi/ml) was added and incubation was continued for an addi-
tional 20 h. After stimulation with 100 nM Ang II for desired time period,
cultures were rinsed free of [32P]orthophosphate, cells were lysed in lysis
buffer (25 mM Tris-HCl, pH 7.4, 25 mM NaCl, 1% Triton X-100, 1%
deoxycholic acid, 1% SDS, 1 mM sodium orthovanadate, 10 mM sodium
fluoride, 10 mM sodium pyrophosphate, 0.5 mM EGTA, 1 mM PMSF, 10
mg/ml aprotinin, and 0.8 mg/ml leupeptin), and then lysates were subjected
to an immunoprecipitation protocol to separate 32P-labeled MARCKS
(Lu et al., 1997). Briefly, cell lysates were mixed with 1 mg/ml anti-
MARCKS antiserum at 48C and incubated overnight with gentle shaking
(Watson and Lenox, 1996). This was followed by incubation with 10 ml aga-
rose-conjugated anti–rabbit IgG for 4 h at 48C. Immunoprecipitates were
collected by centrifugation, washed six times with the lysis buffer, sus-
pended in Laemmli’s buffer, electrophoresed in 4–15% SDS-PAGE and
subjected to autoradiography to detect 32P-labeled bands representing
phosphorylated MARCKS (Yang et al., 1996; Lu et al., 1997).
Treatment of Neuronal Cells with Antisense 
Oligonucleotides or Sense Oligonucleotides to PKC 
Subtypes or MARCKS
Neuronal cultures, established in 35-mm-diam tissue culture dishes, were
incubated with 2.5 mM antisense oligonucleotides (AON) or sense oligo-
nucleotides (SON) to PKC subtypes (a, b, or g) or MARCKS for various
time periods as described elsewhere (Aigner and Caroni, 1993; Balboa et
Figure 3. Effect of PKCb AON and SON on Ang II stimulation of transport of TH, DbH, and [3H]NE uptake activities in the synapto-
somes of brain neurons. Neuronal cultures were pretreated with 2.5 mM PKCb AON or SON for 48 h, essentially as described in Fig. 2.
This was followed by incubation of cells with 100 nM Ang II for 4 h. Synaptosomes were prepared and TH (A), DbH (B), and [3H]NE
(C) uptake activities were determined as described in Materials and Methods. Top in A and B show representative autoradiograms. Bot-
tom, mean data from three experiments 6 SE. Data in C are mean 6 SE (n 5 3). *, significantly different (P , 0.05) from control. **,
significantly different (P , 0.01) from Ang II–treated neurons.
Figure 4. Effects of PKCa
and PKCg AONs on Ang II
stimulation of the transport
of TH in the synaptosomes of
brain neurons. Neuronal cul-
tures were pretreated with
2.5  mM PKCa AON or
PKCg AON for 48 h at 378C.
This was followed by incuba-
tion of cells with 100 nM Ang
II for 4 h. Synaptosomes
were prepared and TH im-
munoreactivity was deter-
mined essentially as de-
scribed in the Materials and
Methods.  Top, representa-
tive autoradiogram. Bottom,
mean of two independent ex-
periments.Lu et al. Involvement of MARCKS in Neuromodulation 221
al., 1994; Yang et al., 1996). Cells were lysed, 50 mg protein from cell ly-
sates were subjected to 4–15% SDS-PAGE, followed by Western blotting
to quantitate PKCa, b, and g subtypes or MARCKS as described above.
Osmotic Loading of Neurons with pep148–165 
and mut148–165
Osmotic loading of neurons with pep148–165 or mut148–165 was carried out es-
sentially as described previously by Ahmad et al. (1995). This method has
recently been adapted by us for neuronal cell culture (Lu et al., 1998). In
brief, neuronal cells were rinsed with PBS, pH 7.4, and incubated for 10
min with a loading solution (0.5 M sucrose, 10% polyethylene glycol 1000,
10% FBS, and 200 mg/ml pep148–165 or mut148–165 in DME buffered with
25 mM Hepes, pH 6.8). Cultures were rapidly rinsed with a hypotonic so-
lution (6.5 vol H20: 3.5 vol DME, buffered with 25 mM Hepes, pH 6.8)
(Reddy et al., 1991; Ahmad et al., 1995), incubated with DME containing
10% PDHS, and were subjected to the experimental protocol for the mea-
surement of Ang II stimulation of synaptosomal TH, DbH, and [3H]NE
uptake as described above.
Experimental Groups and Data Analysis
Each data point represented triplicate culture dishes and cells in these
dishes were derived from multiple brains of 1-d-old WKY rats. Each ex-
periment was replicated three times unless indicated otherwise. Densities
of radioactive bands representing phosphorylated MARCKS or bands on
immunoblots representing MARCKS, PKC subtypes, TH, or DbH were
quantitated by SW5000 Gel Analyzer as described elsewhere (Yang et al.,
1996; Lu et al., 1997). Observed densities (OD) of these bands were such
that they were all in the linear range as previously established by calibrat-
ing protein concentrations with ODs. Data were normalized for equal
loading with the use of equal amounts of proteins in each sample, and
were presented as mean absorbance of at least three experiments’ 6 SE.
Figure 5. Effects of Ang II on neuronal
MARCKS. (A) Effect of Ang II on immunocy-
tochemical localization of MARCKS. Neuronal
cultures were treated without (a and b) or with
100 nM Ang II for 0.5 h (c) and 4 h (d–f) followed
by immunocytochemical analysis of MARCKS
immunoreactivity (a–d). Samples in e and f were
double stained with the use of antibodies to
MARCKS and synaptophysin (e) or MARCKS
and TH (f) essentially as described previously (Lu
et al., 1997). Confocal microscopy was carried out
as described in Methods. Green color represents
MARCKS and TH staining while yellow color
presents co-staining of MARCKS with either syn-
aptophysins (e) or with TH (f). a, depicts beaded
localization of MARCKS in neuronal vercosities.
Little distribution was seen in the cell soma (ar-
row). b, higher magnification of varicosities. c–f,
treatment with Ang II resulted in redistribution
of MARCKS and by 4 h it was uniformly distrib-
uted throughout neurites. (B) Effect of Ang II on
MARCKS phosphorylation. Neuronal culture, pre-labeled with [32P]orthophosphate and incubated with 100 nM Ang II for indicated
time periods. 32P-labeled MARCKS was immunoprecipitated by MARCKS-specific antibody and subjected to SDS-PAGE followed by
autoradiography as described in the Materials and Methods. Top, a representative autoradiogram. Bottom, mean data from three exper-
iments 6 SE. *, significantly different (P , 0.05) from time zero. (C) Effect of Ang receptor antagonists on MARCKS phosphorylation.
Experimental conditions were essentially as described above in Fig. 4 B, except cultures were incubated without (1, 3, 5) or with 100 nM
Ang II (2, 4, 6) in the presence of either 10 mM losartan (3 and 4) or 10 mM PD123,319 (5 and 6). *, significantly different (P , 0.05)
from control. **, significantly different (P , 0.05) from Ang II–treated neurons. Bars in A: (a) 4 mm; (b–e) 4 mm.The Journal of Cell Biology, Volume 142, 1998 222
the levels of immunoreactive synaptophysin was observed
to demonstrate the specificity of Ang II’s actions. The lev-
els of TH and DbH immunoreactivities were compared in
the whole cell homogenates and synaptosomal prepara-
tions of Ang II–treated neurons to further confirm the ef-
fects of Ang II on the transport process. Fig. 1, D and E
show that Ang II caused a 2.7- and 3.9-fold increase in TH
levels in whole cells and synaptosomes, respectively. Simi-
larly, a three- and fivefold increase in DbH levels were
seen in whole cells and synaptosomes. Comparison of data
indicated that the level of TH and DbH stimulation was 30–
40% higher in synaptosomes compared with the whole cells.
Ang II interacts with the AT1 receptor subtype to regu-
late NE neuromodulatory effects (Gelband et al., 1998). In
view of the observations that the AT1 receptor belongs to
G protein–coupled receptor superfamily that is coupled to
PLC-PKC signaling pathway, and that Ang II stimulates
PKC in neurons in a calcium-dependent manner (Sumners
and Raizada, 1993; Sumners et al., 1995; Gelband et al.,
1998), our next aim was to determine which calcium-
dependent PKC subtype was involved in Ang II stimula-
tion of TH, DbH transport, and NE uptake. Fig. 2 shows
that preincubation of neurons with AON to PKCb caused
a time-dependent decrease in PKCb immunoreactivity.
Maximal decrease of 86% was observed with 2.5 mM
PKCb AON in 48 h. In contrast, PKCb SON showed no
such decrease in PKCb immunoreactivity during the same
time period; also in contrast, both PKCb AON and SON
failed to influence immunoreactive levels of PKCa and
PKCg. However, AON to PKCa and PKCg caused a max-
imum of 73% decrease in their respective PKC subtype
immunoreactivities in 48 h (Fig. 2 B). Depletion of PKCb
by its AON was associated with a significant attenuation
of Ang II–induced increase in TH and DbH immunoreac-
tivities and [3H]NE uptake in synaptosomes (Fig. 3, A–C).
This attenuation was specific since PKCb SON or PKCa
and PKCg AONs showed no significant effects on Ang II
stimulation of TH, DbH, and NE uptake. An example of
the lack of effect of PKCa and PKCg AONs on TH immu-
noreactivity is shown in Fig. 4.
Next, we studied the involvement of MARCKS in Ang
II stimulation of NE neuromodulation. The rationale was
based on the evidence that MARCKS is a substrate for
PKC, is present in high concentrations in neurons, and is
proposed to be involved in regulation of neurotransmitter
release (Zhu and Ikeda, 1994; Patel et al., 1995). Fig. 5 A
shows representative images of immunocytochemical dis-
tribution of MARCKS and its colocalization with TH and
synaptophysin in the neurons. MARCKS immunoreactiv-
ity was predominately localized in vesicular structures of
neurites with little distribution in the cell soma (Fig. 5 A, a
and b). This distribution overlapped with the distribution
of immunoreactive synaptophysin in the neurites. Treat-
ment with Ang II resulted in a dramatic redistribution of
MARCKS (Fig. 5 A, c and d). MARCKS immunoreactiv-
ity began to diffuse out of the varicosities and within 30
min it was completely diffused throughout the neurites.
MARCKS immunoreactivity was colocalized with syn-
aptophysin (Fig. 5 A, e) and with TH (Fig. 5 A, f) in Ang
II–treated neurons. This further supports our contention
that AT1 receptor–induced MARCKS redistribution oc-
curs in noradrenergic neurons. A hypothalamic–brainstem
Comparison between experimental data were made using one-way analy-
sis of variance (ANOVA) and Dunnett’s test with Statistica software (Sta-
tistica, Inc., Orlando, FL). [3H]NE uptake was done in triplicate dishes
and data were presented as specific [3H]NE uptake and were mean 6 SE of
triplicate determinations.
Results
Chronic stimulation of NE neuromodulation by Ang II is
mediated by activation of the neuronal AT1 receptor and
is associated with increased expression of genes for TH,
DbH, and NET in neuronal cultures (Lu et al., 1996; Yu
et al., 1996; Gelband et al., 1998). These observations have
led us to hypothesize that stimulation of NE synthesis, re-
lease, and uptake by Ang II is dependent upon the tran-
scription of TH, DbH, and NET genes followed by trans-
port of these activities to the synaptic terminals. Our first
aim in this study was to determine if the transport process
itself was influenced by Ang II. Synaptosomal prepara-
tions showed low but significant basal immunoreactive TH
and DbH (Fig. 1, A and B). Similarly, [3H]NE uptake, a
measure of NET activity, was also low (Fig. 1 C). Treat-
ment with 100 nM Ang II resulted in a time-dependent in-
crease in immunoreactive TH, DbH, and [3H]NE uptake
by synaptosomes. Maximal stimulation of 8.8-, 7.4-, and
7.9-fold in TH, DbH, and [3H]NE uptake, respectively,
was observed in 4 h, and stimulated levels were still evi-
dent 24 h after Ang II treatment. No significant change in
Figure 6. Effect of PKCb AON on Ang II–induced MARCKS
phosphorylation. Neuronal cultures were pre-treated with 2.5 mM
SON or AON for PKCb as described in legend to Fig. 2. After 24 h,
1 mCi/ml [32P]orthophosphate was added to the cultures and in-
cubation was continued for an additional 20 h. 32P-labeled cells
were incubated with 100 nM Ang II for 4 h. Immunoprecipitation
of 32P-labeled MARCKS, followed by its quantitation, was car-
ried out as described in Materials and Methods. Top, a represen-
tative autoradiogram. Bottom, mean 6 SE (n 5 3). *, significantly
different (P , 0.05) from control. **, significantly different (P ,
0.05) from Ang II–treated neurons.Lu et al. Involvement of MARCKS in Neuromodulation 223
neuronal cells in primary culture from 1-d-old rat contain
20–40% TH-positive neurons (Sumners and Raizada,
1993; Raizada et al., 1994). This coupled with our estima-
tion that z30% of neurons express AT1 receptor, would
indicate that significant number of noradrenergic neurons
would be Ang II responsive. In fact, our immunocy-
tochemical observations on Ang II–induced redistribution
of MARCKS depicted in Fig. 5 support this view.
In addition to its redistribution, Ang II also stimulated the
phosphorylation of MARCKS. Fig. 5 B shows a time-depen-
dent increase in the incorporation of 32P in immunoprecipi-
tated MARCKS. Low but significant phosphorylation of
MARCKS was observed in control, untreated neurons. A
twofold stimulation of phosphorylation was seen as early
as 15 min with 100 nM Ang II and maximal stimulation of
4.7-fold was observed in 4 h. The stimulation was com-
pletely blocked by 10 mM losartan, an AT1 receptor sub-
type–specific antagonist and not by 10 mM PD123319, an
AT2 receptor subtype–specific antagonist (Fig. 5 C). Neu-
ronal cultures were preincubated with PKCb AON for 48 h
to specifically deplete them of PKCb subtype. Ang II
failed to stimulate phosphorylation of MARCKS in these
PKCb-depleted neurons (Fig. 6), further supporting our
view that PKCb subtype is involved in this effect.
Cultures were treated with MARCKS AON to deplete
neurons of MARCKS immunoreactivity to determine the
role of MARCKS in Ang II–induced NE neuromodula-
tion. Typical distribution of MARCKS immunoreactivity
in varicosities was seen in untreated, control neurons (Fig.
7 A, a). Pre-incubation of neurons for 48 h with AON to
MARCKS significantly reduced intensity of MARCKS
staining (Fig. 7 A, b). MARCKS SON showed no effect
under these conditions (Fig. 7 A, c). Quantitation of im-
munoreactive MARCKS by Western blotting revealed that
MARCKS AON caused a time-dependent decrease of this
protein and a maximal decrease of 77% was observed in
48 h (Fig. 7 B). MARCKS SON treatment did not reduce
immunoreactive MARCKS. Neurons were pre-treated
with MARCKS AON or SON for 48 h, and then incubated
with 100 nM Ang II for 4 h and levels of TH, DbH, and
[3H]NE uptake in synaptosomes were analyzed. Fig. 8
shows that depletion of MARCKS resulted in a 65–70%
attenuation in the ability of Ang II to stimulate TH and
DbH immunoreactivities and [3H]NE uptake. This effect
on NET, TH, DbH appeared to be posttranscriptional be-
cause MARCKS AON did not effect Ang II stimulation of
mRNAs for these proteins (Fig. 9). Direct effect of Ang II
on the release of [3H]NE from neuronal synaptosomes was
measured to determine if MARCKS is also involved in the
release of catecholamines. Neurons were treated with
MARCKS AON. Synaptosomes were prepared, pre-
Figure 7. Effect of MARCKS AON and SON treatments on neu-
ronal MARCKS. (A) Neuronal cultures were treated without (a)
or with 2.5 mM MARCKS AON (b) or 2.5 mM MARCKS SON
(c) for 48 h. MARCKS immunoreactivity was determined by the
use of confocal microscopy. (B) After treatment with MARCKS
AON or SON for indicated time periods, levels of MARCKS
were determined by Western blotting as described in Materials
and Methods. Top, a representative autoradiogram. Bottom,
mean data 6 SE (n 5 3). *, significantly different (P , 0.01) from
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loaded with [3H]NE and used for Ang II–stimulated re-
lease experiments (Wakade et al., 1995). Basal release of
[3H]NE was comparable in control, MARCKS SON– and
MARCKS AON–treated neurons. Ang II caused a 3.7-
fold increase in specific [3H]NE release from synapto-
somes of control neurons. This accounted for z29% of to-
tal synaptosomal [3H]NE. MARCKS AON treatment did
not alter this level of [3H]NE release. This indicated that, in
spite of a decrease in the intracellular levels of MARCKS,
Ang II–stimulated release of [3H]NE was not affected.
Finally, neuronal cultures were osmotically loaded with
pep148–165 or mut148–165 followed by stimulation with Ang II
to further determine the involvement of MARCKS in the
transport of TH, DbH, and NET. The rationale behind
this experiment was based on the hypothesis that pep148–165
would compete with the native MARCKS for phosphory-
lation by PKCb, and as a result Ang II–mediated phosphor-
ylation of MARCKS would be decreased. Fig. 10 confirms
this prediction and shows that Ang II–induced phosphory-
lation of MARCKS was decreased by 81% in neurons pre-
loaded with pep148–165. Pre-loading with mut148–165 did not
affect Ang II stimulation of MARCKS phosphorylation.
Fig. 11 shows that pep148–165 treatment resulted in 83–87%
decrease in the ability of Ang II to stimulate TH (Fig. 11
A), DbH (Fig. 11 B), and [3H]NE uptake (Fig. 11 C) in syn-
aptosomes. mut148–165 peptide showed no such inhibitory ef-
fect. These data confirm that phosphorylation of MARCKS
by PKCb is an important step in the transport of TH, DbH,
and NET from cell soma to synaptic terminal.
Discussion
The most significant observation of this study is our dem-
onstration that Ang II stimulates redistribution and phos-
phorylation of MARCKS in a PKCb-dependent process,
and that this phosphorylation is involved in the transport
of TH, DbH, and NET in hypothalamic/brainstem neu-
rons. This is of particular interest since MARCKS has re-
cently been shown to be highly expressed in limbic regions
of the brain that retain neuroplastic properties beyond
early development (McNamara and Lenox, 1997). Thus,
MARCKS may play an important role in the mediation of
fast axonal transport of catecholamine-synthesizing en-
zymes and NET to synaptic terminals. As a result, an in-
creased turnover and release of NE is achieved under
chronic stimulation of brain neurons by Ang II.
Ang II has been previously shown to stimulate cate-
cholamines synthesis, turnover, and release both acutely
and chronically (MacLean et al., 1990; Stadler et al., 1992;
Sumners and Raizada 1993; Gelband et al., 1998). These
effects are mediated by activation of the AT1 receptor sub-
type. Acute stimulation, which has been termed evoked
response involves posttranscriptional processes (Lu et al.,
Figure 8. Ang II stimulation of TH and DbH immunoreactivities, and [3H]NE uptake in MARCKS-depleted neurons. Neuronal cul-
tures were pretreated with 2.5 mM MARCKS SON or AON for 48 h essentially as described in the legend to Fig. 7. Synaptosomal prep-
aration was used to quantitate immunoreactive TH (A) or DbH (B) or specific [3H]NE uptake (C) as described in Materials and Meth-
ods. Top in A and B are representative autoradiograms. Bottom in A and B represented mean 6 SE (n 5 3). Data in C are mean 6 SE
(n 5 3). *, significantly different (P , 0.01) from control. **, significantly different (P , 0.01) from Ang II–treated neurons.
Figure 9. Effects of MARCKS AON treatment on TH, DbH,
and NET mRNA levels in neurons. Neuronal cultures were pre-
treated with 2.5 mM MARCKS AON or SON for 48 h. After in-
cubation without or with 100 nM Ang II for 4 h, total RNA was
isolated and mRNA levels for TH (A), DbH (B), and NET (C)
were measured by reverse transcription PCR essentially as estab-
lished by us previously (Lu et al., 1996; Yu et al., 1996).Lu et al. Involvement of MARCKS in Neuromodulation 225
1996), whereas a chronic or enhanced response of Ang II
is associated with both translocation of pre-existing intra-
cellular NET and transcription of NET, TH, and DbH
genes. (Lu et al., 1996; Yu et al., 1996; Gelband et al.,
1998). This may explain the observation that Ang II stimu-
lation of NET activity occurs more rapidly as compared
with its effect on TH and DbH (Fig. 1). Our studies have
also established that the enhanced regulation of Ang II–
induced NE neuromodulation requires activation of Ras-
Raf-MAP kinase signal transduction pathway (Yang et al.,
1996; Lu et al., 1997; Gelband et al., 1998). Activation of
MAP kinase leads to nuclear translocation of MAP kinase
and other signaling molecules such as Fos, STAT3, and
Jun, which participate in transcriptional control of TH,
DbH, and NET (Gelband et al., 1998). In this study we
have presented evidence for an additional signaling path-
way that we believe is equally important in enhanced re-
sponse of NE neuromodulation by Ang II. In this scheme,
we propose that Ang II stimulates transport of TH, DbH,
and NET along the neurites for them to be available for
increased synthesis, release, and re-uptake of NE at the
synaptic level. This stimulation involves activation of PKCb:
(a) Ang II stimulates PKC, which is involved in axonal
transport (Komoly et al., 1991); (b) treatment of neurons
with AON to PKCb, which selectively depletes neurons of
this subtype, causes attenuation of Ang II stimulation of
TH, DbH, and NET transport. This effect is selective for
PKCb subtype since AONs to other major calcium-depen-
dent PKC subtypes such as PKCa and PKCg had no such
effect. It is also pertinent to point out that Ang II–induced
MARCKS phosphorylation and redistribution appears to
be a relatively slower response compared with its relatively
rapid effect on PKC. Although, we have suggested that
PKCb stimulation is directly involved in Ang II–induced
MARCKS phosphorylation and redistribution. Alternate
possibilities can not be ruled out at the present time. For
example, it is possible that Ang II influences PKCb-depen-
dent neuronal activity. A change in this activity could activate
an entire set of distinct neurons to stimulate redistrubu-
tion of MARCKS, TH, and DbH. However, our observa-
tions that AT1 receptors are present on nonadrenergic
neurons and that the AT1 receptor blockade attenuates
NET activity in these neurons (Lu et al., 1996) argue against
such an indirect effect.
Phosphorylation of MARCKS is instrumental in its re-
distribution. MARCKS possesses a basic phosphorylation
site domain (PSD). Phosphorylation of this PSD domain
prevents the electrostatic interaction of the effector region
of the MARCKS to the plasma membrane (George and
Blackshear, 1992; Taniguchi and Manenti, 1993; Kim et al.,
1994). Whereas there is little evidence for a preferential
phosphorylation of MARCKS by the PKCb subtype, there
is considerable evidence for its presence and involvement in
synaptosomal activities (Guadagno et al., 1992; Heemskerk
et al., 1993; Sheu et al., 1995; Cabell et al., 1996; Seki et al.,
1996). Present data are novel since they provide evidence
that PKCb subtype is involved in Ang II stimulation of
MARCKS phosphorylation, redistribution, and in NE neuro-
modulation. The evidence for this includes the following:
(a) Ang II stimulation of phosphorylation of MARCKS is
blocked by depletion of PKCb by AON treatment. No
such attenuation was observed with AON to PKCa or PKCg;
(b) Ang II–induced redistribution of immunoreactive
MARCKS from varicosities is also blocked by PKCb-
AON treatment; (c) Presence of PKC substrate domain is
well documented in MARCKS and a peptide containing
this domain blocks Ang II stimulation of MARCKS phos-
phorylation.
Finally, phosphorylation of MARCKS appears to be key
in its redistribution and increased accumulation of TH,
DbH, and NET in synaptic vesicles: (a) blocking the phos-
phorylation of MARCKS by pep148–165 inhibits Ang II–
induced redistribution of MARCKS in neurites. As a re-
sult, MARCKS immunoreactivity remains localized in the
varicosities (unpublished data); (b) AON to MARCKS,
that significantly reduces endogenous levels of neuronal
MARCKS, attenuates Ang II–induced accumulation of
TH, DbH, and NET in synaptosomes; (c) Ang II induces
redistribution of MARCKS. Such a PKC-activated redis-
tribution has been proposed in membrane trafficking and
cycling of MARCKS between plasma membrane and lyso-
somes in other systems (Allen and Aderem, 1995); and (d)
blocking the phosphorylation of MARCKS by osmotic
loading of the peptide148–165 attenuates Ang II enhance-
ment of TH and DbH in synaptosomes. Collectively, these
observations strongly support the notion that PKCb-
MARCKS are facilitating signaling pathway in enhanced
regulation of NE neuromodulation by Ang II.
Figure 10. Effect of MARCKS pep148–165 and mut148–165 on Ang II
stimulation of phosphorylation of MARCKS. Neuronal cultures
were prelabeled with [32P]orthophosphate and subjected to os-
motic loading of MARCKS pep148–165 and mut148–165 essentially as
described in Materials and Methods. After incubation with 100 nM
Ang II for 4 h, radiolabeled MARCKS was immunoprecipitated
and subjected to quantitation as described in Materials and Meth-
ods. Top, a representative autoradiogram. Bottom, mean absor-
bance data 6 SE (n 5 3). *, significantly different (P , 0.05) from
control. **, significantly different (P , 0.05) from Ang II–treated
neurons.The Journal of Cell Biology, Volume 142, 1998 226
These observations are important in that they provide
the first evidence that two distinct signaling pathways in-
duced by AT1 receptor activation, converge downstream
to participate in the enhanced stimulation of neuromodu-
lation. Such long-term enhancement of noradrenergic neu-
rotransmission has been shown to involve an increase in
critical proteins such as TH and DbH and their transport
to synaptic sites. Studies over the years have provided data
in support of the close association of both TH and DbH
transport and the association of organelles in the process
(Coyle and Wooten, 1972; Dahlstrom et al., 1982).
Whereas it has been clear that microtubule-dependent
movement is essential to transport associated with a vari-
ety of intracellular organelles, it is only more recently that
a role for actin microfilaments in this process has been elu-
cidated (Morris and Hollenbeck, 1995). In fact, there is ex-
tensive interaction between microtubules and the actin cy-
toskeleton, and it has been suggested that the specialized
properties of these two cytoskeletal filament systems may
act in a coordinated manner to achieve regional and even
compartmentalized net transport of organelles and associ-
ated proteins for proper physiological regulation (Gold-
stein and Vale, 1992; Morris and Hollenbeck, 1995).
MARCKS is a member of a small family of proteins that
bind calmodulin in the presence of calcium and bind and
cross-link actin in a mutually exclusive fashion. PKC-medi-
ated phosphorylation prevents both calmodulin binding
and actin cross-linking and shuttles MARCKS out of the
plasma membrane (Wang et al., 1989; Rosen et al., 1990;
Thelen et al., 1991). Recent studies have demonstrated
that MARCKS is transported from plasma membrane to
lysosomes upon PKC-mediated phosphorylation, and re-
cycling of MARCKS to the plasma membrane appears to
depend upon interaction with intact microtubules (Allen
and Aderem, 1995). By virtue of the fact that MARCKS’
intracellular location and properties are responsive to cell
signaling events, there is significant evidence that
MARCKS may play an important role in translating extra-
cellular signal–mediated cytoskeletal restructuring associ-
ated with cell movement, phagocytosis, and neurosecre-
tion (Aderem, 1995; Blackshear, 1993; Wang et al., 1989).
Both calcium flux and PKC activation are in a position to
prevent MARCKS-mediated actin cross-linking, thus al-
tering the dynamic interaction of microtubules and actin
filaments, leading to a reduction in membrane rigidity and
facilitation of transport of macromolecules in the neurites
(Hartwig et al., 1992). It is also possible that calmodulin,
released from MARCKS phosphorylation, is involved
in accelerating the transport process. This proposal is con-
sistent with the demonstrated involvement of calmodulin
in Ang II stimulation of TH in particular, and its role in
axonal transport and neuromodulation in general (Graff
et al., 1989; Hammerschlag, 1994; Rivera et al., 1995).
Thus both the release of calmodulin and the inability of
phosphorylated MARCKS to form actin crossbridges may
be involved in Ang II–induced chronic neuromodulation.
Studies are underway to delineate these processes as they
relate to Ang II–induced phosphorylation of MARCKS
and transport of TH, DbH, and NET.
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